Quintiles Information Library Custom Feed

Pioneering Pulmonary Research

Tue, 08 May 2012 16:23:33 -0400

Discover how Quintiles helped one sponsor modify their recruitment sites to generate the desired number of qualified patients to meet timelines in this Phase II double-blind, placebo-controlled efficacy and safety study for COPD patients with emphysema. Download the PDF

Validated Methods

Wed, 02 May 2012 16:55:01 -0400

Advion Bioanalytical Labs specializes in validated LC/MS methods development to support drug-drug interaction (DDI), biomarker, or comparison studies with established therapeutic compounds. Non-proprietary, validated methods Download the PDF

CYP450 Inhibition Studies

Wed, 02 May 2012 16:50:50 -0400

Many aspects of our assays can also be customized to provide you with the type of data and degree of quality assuredness that you require. Download the PDF

LC-MS-MS Services

Wed, 02 May 2012 16:46:48 -0400

At Advion Bioanalytical Labs, our scientists have years of bioanalytical method development and LC/MS/MS expertise to meet study needs. Download the PDF

Immunoassay Services

Wed, 02 May 2012 16:39:05 -0400

Advion Bioanalytical Labs provides a full range of immunoassays services, including ELISA assays, for the development and validation of traditional and custom-designed PK, immunogenicity testing, and biomarker projects. Download the PDF

Biomarker Services

Wed, 02 May 2012 16:28:08 -0400

At Advion Bioanalytical Labs, our highly trained scientists utilize novel techniques and state of the art technology to develop customized solutions for your biomarker challenges. Download the PDF

Sample Management Services

Wed, 02 May 2012 15:36:19 -0400

The Sample Management and Storage Services team supports single- or multi-site studies with hundreds to thousands of samples worldwide. Download the PDF

Quintiles Infosario Streamlining Trials with Better Communication

Mon, 12 Mar 2012 13:38:32 -0400

The Quintiles Infosario™ Investigator Portal fundamentally changes the way clinical trial lab work is managed. Putting timely laboratory data at the fingertips of investigators, this advanced system offers greater transparency and efficiency to tighten study timelines and increase the quality of data. Download the PDF

India Central Laboratory Services

Mon, 06 Feb 2012 15:45:17 -0400

Quintiles offers a local presence in India alongside seven other wholly owned labs and two affiliates strategically located around the world. Over time, we have developed key relationships in local regulatory and shipping communities, giving us the ability to support investigators in India, elsewhere in Asia or around the globe. Download the PDF

South Africa Central Laboratory Services

Mon, 06 Feb 2012 10:37:14 -0400

Quintiles offers a local presence in Africa alongside seven other wholly owned labs and two affiliates strategically located around the world. Over time, we have developed key relationships in local regulatory and shipping communities, giving us the ability to support investigators in Africa or around the globe. Download the PDF

DIA US 2012

Thu, 12 Jan 2012 11:06:15 -0400

Quintiles will have an exhibit

Intarcia and Quintiles Finalize Innovative Alliance

Tue, 13 Dec 2011 07:43:17 -0400

December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

Quintiles Launches China CRO, Kun Tuo

Tue, 13 Dec 2011 07:01:52 -0400

December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

Quintiles Expands World's Largest Cap-Accredited Lab Network

Thu, 01 Dec 2011 08:00:00 -0400

December 1, 2011 – Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles announced the opening of a new, expanded central lab in Centurion, South Africa.

Quintiles and Prodia Partner to Provide Central Lab Testing Solution in Indonesia

Wed, 30 Nov 2011 02:00:00 -0400

November 30, 2011 – Quintiles announced an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing of samples from patients in clinical trials in Indonesia.

Quintiles Completes Acquisition of Advion BioServices

Mon, 07 Nov 2011 06:00:00 -0400

November 7, 2011 – Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.

Quintiles Agrees to Acquire Premier GLP Bioanalytics Laboratory

Wed, 26 Oct 2011 09:03:53 -0400

October 26, 2011 – To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles signed of a definitive agreement to acquire Advion BioServices.

Quintiles Addresses Key Considerations for Successful Biosimilar Development

Fri, 30 Sep 2011 14:53:19 -0400

September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

Partnering is Key to Maximizing Rewards in Emerging Markets

Tue, 27 Sep 2011 06:00:00 -0400

September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

Thu, 23 Jun 2011 14:33:45 -0400

In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. Download the PDF

Digital Pathology Central Laboratory Services Fact Sheet

Thu, 23 Jun 2011 14:23:15 -0400

This fact sheet highlights Quintiles' digital pathology services, covering everything from scanning of slides to review and analysis - giving you a faster, easier way to scan and share this critical research data. Download the PDF

Genomics Fact Sheet

Fri, 17 Jun 2011 15:45:36 -0400

Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area. Download the PDF

Quintiles Appoints New Head of Late Phase Operations

Thu, 09 Jun 2011 09:19:39 -0400

June 9, 2011 – Quintiles announced the appointment of Dr. Cynthia L. Verst as Global Head of Late Phase Operations.

Translational R&D Services Fact Sheet

Thu, 26 May 2011 17:45:56 -0400

Quintiles’ Translational R&D Center of Excellence performs groundbreaking research and offers novel findings in oncology for biopharmaceutical companies. Download the PDF

Quintiles Names Rick Sax New Head of Integrated Clinical Services

Mon, 23 May 2011 09:30:00 -0400

May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.

Quintiles and Population Genetics Technologies Partner

Mon, 16 May 2011 00:00:00 -0400

May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

Dr. Frank Massam

Fri, 13 May 2011 22:01:05 -0400

Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

Asia-Pacific Expertise

Wed, 11 May 2011 13:06:56 -0400

Quintiles' experience and flexibility to understand cultural and communication differences across Asia Pacific provided an integrated solution which exceeded recruitment targets. Download the PDF

Biomarkers in Alzheimers Disease

Thu, 17 Mar 2011 09:06:55 -0400

The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. Download the PDF

Quintiles Central Laboratory Awarded Accreditation to the International Standard for Quality Management

Wed, 23 Feb 2011 09:50:01 -0400

February 23, 2011 – Quintiles lab is one of only of a limited number of central labs in the U.S. to meet the rigorous requirements for medical laboratory quality and competence established by the International Organization for Standardization (ISO).

Clinical – Smarter Trials, Accelerated Outcomes

Wed, 16 Feb 2011 09:25:24 -0400

Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. Download the PDF

Scientific Bulletin Flow Cytometry

Wed, 09 Feb 2011 16:46:16 -0400

Quintiles has expertise in running highly regulated flow cytometry assays, as well as a number of esoteric assays, such as multicolor cell surface and intracellular staining assays, and receptor occupancy/competitive binding assays. Download the PDF

Oversight Group Management Services - Aligned Action

Wed, 02 Feb 2011 13:56:49 -0400

From data monitoring committees and endpoint adjudication to core laboratory oversight, Quintiles provides a one-stop solution for managing oversight groups. Download the PDF

Bypassing Barriers - Refractory Partial Epilepsy

Wed, 02 Feb 2011 11:24:17 -0400

Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule. Download the PDF

Diabetes - Therapeutic Focus

Tue, 01 Feb 2011 14:12:57 -0400

A dose-ranging clinical study to evaluate the safety, efficacy and tolerability of five doses of Drug X compared with placebo in Type II diabetes patients with no prior exposure to anti-diabetic medication. Download the PDF

Acute Coronary Syndrome - Tailored Solutions

Tue, 01 Feb 2011 13:22:42 -0400

Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO. Download the PDF

Oncology Expertise - Scientific Collaborator for Global Solutions

Fri, 28 Jan 2011 10:01:54 -0400

Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you. Download the PDF

QUINTILES, LONDON GENETICS ALLY TO ENHANCE DRUG DISCOVERY AND DEVELOPMENT THROUGH PHARMACOGENETICS

Mon, 29 Nov 2010 09:00:00 -0400

November 29, 2010 – Quintiles, London Genetics alliance combines world-class expertise, global infrastructure to support biopharma in developing personalized medicine.

Beijing, China Central Laboratory Services Fact Sheet

Wed, 17 Nov 2010 10:36:20 -0400

This fact sheet demonstrates Quintiles long history of supporting clinical trials in China, including a constantly expanding list of services. Download the PDF

BIOMODA SELECTS QUINTILES TO HELP DEVELOP MORE ACCURATE AUTOMATED SYSTEM FOR DETECTING EARLY-STAGE LUNG CANCER

Mon, 15 Nov 2010 09:00:00 -0400

November 15, 2010 – Cancer diagnostics company Biomoda, Inc. has allied with Quintiles' Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath®-stained cells to detect early stage lung cancer.

DAKO AND QUINTILES FORM ALLIANCE TO SPEED DEVELOPMENT OF PERSONALIZED MEDICINE

Mon, 01 Nov 2010 09:00:00 -0400

November 1, 2010 - Dako and Quintiles announced a strategic alliance to advance personalized medicine by collaborating on the co-development of targeted therapies and companion diagnostics.

Podcast: Clinical Development of Cancer Drugs in China

Mon, 18 Oct 2010 11:34:18 -0400

Hear exclusive interviews with Quintiles's experts, Christopher Ung, Patty James and Harish Dave on their recent participation at the 13th Annual Chinese Society of Clinical Oncology

Scientific Bulletin PI3K Biomarker Assay

Fri, 15 Oct 2010 17:23:37 -0400

This PI3K Biomarker Assay scientific bulletin reviews test highlights, disease overview and testing methodology. Download the PDF

Data Transfer Express

Wed, 13 Oct 2010 13:38:41 -0400

An innovative solution to the challenging data transfer requirements of Eli Lilly. Download the PDF

Managing Trauma

Tue, 14 Sep 2010 16:58:57 -0400

Quintiles overcame the unpredictability of patient recruitment due to the emergency setup and the client was able to file for approval based on phase II data only. Download the PDF

QUINTILES CENTRAL LABORATORY IN JAPAN RECEIVES CAP ACCREDITATION

Tue, 07 Sep 2010 06:00:00 -0400

September 7, 2010 - Quintiles' new lab in Tokyo, Japan has received accreditation from the College of American Pathologists (CAP), joining the largest network of fully harmonized, CAP-accredited central labs in the world.

The New Health Clinical Brochure

Tue, 31 Aug 2010 14:34:37 -0400

Japanese version available for download. Download the PDF

Central Laboratory Solutions

Fri, 11 Jun 2010 10:49:17 -0400

Central laboratory solutions from Quintiles -- the science to get it right, the resources to make it easy Download the PDF

New Frontiers

Tue, 08 Jun 2010 21:24:59 -0400

By utilizing a deliberately flexible monitoring schedule, Quintiles was able to accommodate fluxes in enrollment and substantial variations in enrollment from site to site. Download the PDF

QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY

Mon, 07 Jun 2010 09:00:00 -0400

June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.

QUINTILES GLOBAL CENTRAL LAB IN CHINA EARNS PRESTIGIOUS NATIONAL AWARD FROM LEADING MEDICAL CENTER

Tue, 30 Mar 2010 11:24:05 -0400

March 30, 2010 – Quintiles’ Global Central Laboratory in China has won the national “Best Central Lab 2009” award from Shanghai Mental Health Center.

Tissue Biomarkers and Digital Pathology in Oncology Clinical Development

Fri, 26 Mar 2010 12:20:42 -0400

Tissue Biomarkers & Digital Pathology in Oncology Clinical Development presented by Christopher Ung, VP Strategic Business & Operations, Oncology at Asia Pharma in March 2010. Download the PDF

Tissue Biomarkers and Digital Pathology in Oncology Clinical Development

Fri, 26 Mar 2010 12:20:42 -0400

Tissue Biomarkers & Digital Pathology in Oncology Clinical Development presented by Christopher Ung, VP Strategic Business & Operations, Oncology at Asia Pharma in March 2010. Download the PDF

QUINTILES ANNOUNCES NEW CENTRAL LAB IN JAPAN

Mon, 15 Mar 2010 18:00:00 -0400

March 15, 2010 – Quintiles announces that it has successfully relocated its Global Central Laboratory in Japan from Saitama to Tokyo to allow for expansion.

PharmAsia News Article Reprint

Mon, 01 Mar 2010 09:21:33 -0400

Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News. Download the PDF

Biomarker Trends in Breast Cancer Research

Wed, 24 Feb 2010 16:30:43 -0400

Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. Download the PDF

QUINTILES ADDS TISSUE TESTING SERVICES IN CHINA

Tue, 16 Feb 2010 09:43:33 -0400

February 16, 2010 - Quintiles announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments.

Quintiles’ Christopher Ung Discusses the Future of Biomarkers, Digital Pathology and Personalized Medicine in PharmaAsia

Tue, 09 Feb 2010 12:49:30 -0400

Christopher Ung, Vice President, Strategic Business and Operations, Oncology, recently authored an article on biomarkers, digital pathology and the future of personalized medicine for the

QUINTILES EXECUTIVE ELECTED CHAIR-ELECT OF CDISC

Tue, 19 Jan 2010 09:30:17 -0400

January 19, 2010 – Quintiles announced that Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, has been elected chair-elect of the Board of Directors of CDISC.

QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

Fri, 06 Nov 2009 10:47:04 -0400

November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS

Thu, 24 Sep 2009 11:39:33 -0400

September 24, 2009 - Quintiles Transnational Corp. announced the opening of an expanded regional facility near Edinburgh, Scotland; space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management.

Tissue Biomarkers in Oncology Clinical Development: The Digital Advantage

Tue, 15 Sep 2009 14:32:48 -0400

The advantages of incorporating digital pathology into your oncology clinical development process. Download the PDF

QUINTILES ADDS DIGITAL PATHOLOGY SERVICES

Mon, 14 Sep 2009 10:45:23 -0400

September 14, 2009 - Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announced the availability of digital pathology services in Beijing, China. The services add to Quintiles offerings used in the development of therapies to treat the world’s most pressing health issues, including cancer.

Podcast: Changing the Face of Cancer Research

Mon, 31 Aug 2009 12:13:18 -0400

Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. Download the PDF

Podcast: Changing the Face of Cancer Research

Mon, 31 Aug 2009 12:13:18 -0400

Validated Biomarker Menu

Tue, 14 Jul 2009 11:00:55 -0400

A comprehensive menu of validated cell, fluid and tissue based biomarker assays. Download the PDF

Claire Huguet

Wed, 08 Jul 2009 10:18:34 -0400

Dr. Claire Huguet, an expert in clinical laboratory operations and biomarkers, brings more than 20 years of experience to Quintiles Central Laboratories.

The Future of Data Management

Tue, 30 Jun 2009 11:12:59 -0400

Paula Brown Stafford, MPH EVP, Integrated Clinical Services

Validated Biomarker Menu

Wed, 10 Jun 2009 14:45:56 -0400

This is a fact sheet that contains information about validated biomarkers. Download the PDF

The Importance of Latin America

Mon, 08 Jun 2009 10:16:44 -0400

Video showing why Latin America’s a great option for Clinical trials. With a total population over 500 million people and only two major languages, you will find a world of opportunity in the region.

India Today: Quintiles Central Laboratory

Mon, 08 Jun 2009 10:14:39 -0400

Video explaining why India’s a great option for clinical trials. Benefits include access to patients, potential cost savings, experienced investigators, and state of the art technology.

India Rising: Quintiles Central Laboratory

Mon, 08 Jun 2009 09:46:05 -0400

We take look at the rising role of India and Quintiles' ability to offer central laboratory services that continue to meet you needs for clean, reliable and comparable data for your regulatory submissions.

Building Bridges

Tue, 02 Jun 2009 15:09:57 -0400

Pharmaceutical companies are recognizing that a preferred provider relationship with a central lab service provider can bridge processes across projects and enable a consistent platform across an entire drug program. Download the PDF

QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS

Mon, 25 May 2009 11:43:19 -0400

May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.

QUINTILES GLOBAL CENTRAL LABORATORY NETWORK SETS NEW STANDARD

Wed, 11 Mar 2009 14:13:15 -0400

March 11, 2009 – Quintiles Transnational Corp. has the largest CAP-accredited central laboratory network in the world - setting a standard for patient safety and faster drug development.

QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDITATION

Wed, 11 Mar 2009 09:14:44 -0400

March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network.

Partnering with Central Labs

Mon, 26 Jan 2009 12:34:22 -0400

Bridging the gaps in biomarker development and testing for global clinical trials biomarkers, digital pathology and the central lab. Download the PDF

QUINTILES TO PROVIDE CENTRAL LAB SERVICES IN JAPAN

Wed, 26 Mar 2008 17:45:39 -0400

March 26, 2008 – Quintiles Transnational Corp. announced an agreement with Medca Japan to provide central laboratory services, further extending the Quintiles global network of laboratories certified by the College of American Pathologists (CAP).

QUINTILES CENTRAL LAB, CLINICAL DEVELOPMENT IN CHINA TO EXPAND, RELOCATE TO NEW FACILITY

Wed, 09 Jan 2008 17:57:04 -0400

January 9, 2008 – Quintiles Transnational Corp. announced the expansion and consolidation of its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing to accommodate their growing business in China.